OQS
ACET icon

Occudo Quantitative Strategies’s Adicet Bio ACET Stock Holding History

Occudo Quantitative Strategies’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114K Buy
+15,100
New +$113K 0.01% 703
2024
Q1 		– Sell
-4,767
Closed -$144K – 706
2023
Q4 		$144K Sell
4,767
-304
-6% -$6.63K 0.02% 683
2023
Q3 		$111K Sell
5,071
-3,900
-43% -$138K 0.01% 869
2023
Q2 		$349K Buy
+8,971
New +$792K 0.04% 694

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Occudo Quantitative Strategies's ACET Position: Q1 2026 in Review

Occudo Quantitative Strategies opened a new position in Adicet Bio (ACET) in Q1 2026: 15,100 shares worth $114K. The stake represents 0.01% of the portfolio and ranks #703 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in ACET as recently as Q4 2023.

Occudo Quantitative Strategies first reported a position in ACET in Q2 2023 and has held it in 4 quarters since. The position peaked at $349K in Q2 2023. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Occudo Quantitative Strategies held 15,100 shares of Adicet Bio worth $114K as of Q1 2026.
  • Adicet Bio was a new Occudo Quantitative Strategies position in Q1 2026.
  • Adicet Bio made up 0.01% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #703 holding.
  • Occudo Quantitative Strategies first reported a position in Adicet Bio in Q2 2023 and has held it in 4 quarters since.
  • Occudo Quantitative Strategies's Adicet Bio position peaked at $349K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.